Treatment Effectiveness
User reported effectiveness ratings Eszopiclone (Lunesta) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Insomnia | 16% | 29% | 9% | 31% | 15% | 104 |
Side Effects
User-reported side effects of Eszopiclone (Lunesta)
| Side Effect | Percent of Reports Eszopiclone (Lunesta) |
|---|---|
| Dry Mouth | 20% |
| Heartburn | 0% |
| Breast Enlargement in Males | 4% |
| Daytime Drowsiness | 35% |
| Decreased Sexual Desire | 13% |
| Dizziness | 32% |
| Lightheadedness | 24% |
| Loss of Coordination | 24% |
| Painful Menstrual Periods | 0% |
| Unpleasant Taste | 37% |
| Unusual Dreams | 28% |
| Vomiting | 4% |
| Headache | 27% |
| Nausea | 17% |
| Pain | 8% |
Outcomes
Below is the degree of change seen after Eszopiclone (Lunesta) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Outcomes Label
Eszopiclone (Lunesta) Info
| Property | Value |
|---|---|
| Variable Name | Eszopiclone (Lunesta) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-03-29 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 30 minutes |
| Unit | Count |
| User Variables | 0 |
| Variable Category | Treatments |
| Variable ID | 93514 |